Aug 2026 $79 M No. 9 $50 to $250 million 3
Alzheon, Inc.: Raise no. 9, Aug 2026 × Investors in this round 3 investors had bought by the notice of Sep 10, 2026: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $79 M of $500 M offered; $421 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Adem K. Albayrak · Executive Officer · Chief Data Officer Aidan K. Power, MRCPsych · Executive Officer · Chief Development Officer John K. Hey, Ph.D. · Executive Officer · Chief Scientific Officer Kenneth K. Mace · Executive Officer · Treasurer and Chief Financial Officer Martin Tolar, M.D., Ph.D. · Executive Officer, Director · President and Chief Executive Officer Susan K. Abushakra, M.D. · Executive Officer · Chief Medical Officer Christopher Noel Dunn · Director Diane K. Jorkasky, M.D. · Director Gino K. Santini · Director Jordan W. Heller · Director Muneer K. Satter · Director Neil W. Flanzraich · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Martin Tolar, M.D., Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 10, 2026. Read the notice at the SEC .
equity SEC Feb 2024 $126 M No. 8 $50 to $250 million 76
Alzheon, Inc.: Raise no. 8, Feb 2024 × Investors in this round 76 investors had bought by the notice of Feb 10, 2025: 76 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $126 M of $150 M offered; $24 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Adem E. Albayrak · Executive Officer · Chief Data Officer Aidan K. Power, MRCPsych · Executive Officer · Chief Development Officer Glenn E. Pauly · Executive Officer · Chief Commercial Officer John K. Hey, Ph.D. · Executive Officer · Chief Scientific Officer Kenneth A. Mace · Executive Officer · Treasurer and Chief Financial Officer Martin Tolar, M.D., Ph.D. · Executive Officer, Director · President and Chief Executive Officer Susan K. Abushakra, M.D. · Executive Officer · Chief Medical Officer Christopher Noel Dunn · Director Diane K. Jorkasky, M.D. · Director Gino K. Santini · Director Jordan W. Heller · Director Muneer E. Satter · Director Neil W. Flanzraich · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Martin Tolar, M.D., Ph.D., President and Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Feb 10, 2025. Read the notice at the SEC .
equity SEC Dec 2022 $2 M No. 7 Under $2 million 6
Alzheon, Inc.: Raise no. 7, Dec 2022 × Investors in this round 6 investors had bought by the notice of Jan 11, 2023: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $50 M offered; $48 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Aidan K. Power, MRCPsych · Executive Officer · Chief Development Officer John K. Hey, Ph.D. · Executive Officer · Chief Scientific Officer Kenneth A. Mace · Executive Officer · Treasurer and Chief Financial Officer Martin Tolar, M.D., Ph.D. · Director, Executive Officer · President and Chief Executive Officer Susan K. Abushakra, M.D. · Executive Officer · Chief Medical Officer Christopher Noel Dunn · Director Diane K. Jorkasky, M.D. · Director Jordan W. Heller · Director Neil W. Flanzraich · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Martin Tolar, M.D., Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 11, 2023. Read the notice at the SEC .
equity SEC Sep 2020 $2 M No. 6 $2 to $10 million 5
Alzheon, Inc.: Raise no. 6, Sep 2020 × Investors in this round 5 investors had bought by the notice of Sep 30, 2020: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $50 M offered; $48 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John K. Hey, Ph.D. · Executive Officer Kenneth A. Mace · Executive Officer · Treasurer/VP Finance Martin Tolar, M.D., Ph.D. · Director, Executive Officer · President and Chief Executive Officer Susan K. Abushakra, M.D. · Executive Officer Diane K. Jorkasky, M.D. · Director Jordan W. Heller · Director Neil W. Flanzraich · Director Noel W. Dunn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Martin Tolar, M.D., Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 30, 2020. Read the notice at the SEC .
equity SEC Apr 2019 $6 M No. 5 $2 to $10 million 13
Alzheon, Inc.: Raise no. 5, Apr 2019 × Investors in this round 13 investors had bought by the notice of Jan 15, 2020: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity, other: Conversion of Convertible Promissory Notes Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Kenneth A. Mace · Executive Officer · Treasurer/VP Finance Martin Tolar, M.D., Ph.D. · Director, Executive Officer · President and Chief Executive Officer David W. Nikodem, Ph.D. · Director Diane K. Jorkasky, M.D. · Director Jordan W. Heller · Director Neil W. Flanzraich · Director Noel W. Dunn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount and Total Amount Sold also include the conversion of Promissory Notes.”Signed by Martin Tolar, M.D., Ph.D., President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 15, 2020. Read the notice at the SEC .
equity SEC May 2017 $20 M No. 4 $10 to $50 million 81
Alzheon, Inc.: Raise no. 4, May 2017 × Investors in this round 81 investors had bought by the notice of Sep 5, 2018: 81 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $20 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $189,955
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Kenneth A. Mace · Executive Officer Martin Tolar · Executive Officer, Director David Nikodem · Director Dennis Langer · Director Franz Hefti · Director Jean-Pierre Garnier · Director Neil W. Flanzraich · Director Scott Minick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round CIM Securities, LLC · New York, New York Sold in CA, CO, DE, FL, IL, MA, MD, NJ, NY, TX, WY Remarks in the notice On the amounts: “Total Offering Amount and Total Amount Sold also include the conversion of Promissory Notes.”Signed by Martin Tolar, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 5, 2018. Read the notice at the SEC .
equity SEC Feb 2016 $1 M No. 3 Under $2 million 3
Alzheon, Inc.: Raise no. 3, Feb 2016 × Investors in this round 3 investors had bought by the notice of Feb 26, 2016: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $5 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $78,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Ken Mace · Executive Officer Martin Tolar · Executive Officer, Director David Nikodem · Director Dennis Langer · Director Franz Hefti · Director Jean-Pierre Garnier · Director Scott Minick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round CIM Securities, LLC (CRD 120852) · New York, New York Sold in CA, CO, FL, IL, MA, MD, NY, TX, WY Signed by Martin Tolar, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 26, 2016. Read the notice at the SEC .
debt, options SEC Jul 2015 $7 M No. 2 $2 to $10 million 26
Alzheon, Inc.: Raise no. 2, Jul 2015 × Investors in this round 26 investors had bought by the notice of Jul 27, 2015: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $402,344
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John Hey · Executive Officer Martin Tolar · Executive Officer, Director Michael Aceti · Executive Officer Robert Silverman · Executive Officer David Nikodem · Director Franklin Berger · Director Franz Hefti · Director Jean-Pierre Sommadossi · Director Menghis Bairu · Director Scott Minick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Brookline Group, LLC (CRD 153587) · Birmingham, Alabama Sold in AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY Signed by Martin Tolar, President. Source: SEC Form D, newest notice filed Jul 27, 2015. Read the notice at the SEC .
debt, options SEC Dec 2014 $7 M No. 1 $2 to $10 million 60
Alzheon, Inc.: Raise no. 1, Dec 2014 × Investors in this round 60 investors had bought by the notice of Feb 25, 2015: 60 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $720,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice John Hey · Executive Officer Martin Tolar · Executive Officer, Director Michael Aceti · Executive Officer David Nikodem · Director Franklin Berger · Director Franz Hefti · Director Jean-Pierre Sommadossi · Director Menghis Bairu · Director Scott Minick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Brookline Group, LLC (CRD 153587) · Birmingham, Alabama Sold in AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY Remarks in the notice On the use of proceeds: “The Company shall use some of the offering proceeds to pay salaries to executive officers in the ordinary course of business but shall not make any transaction based payments in connection with the offering.”Signed by Martin Tolar, President. Source: SEC Form D and 1 amendment, newest notice filed Feb 25, 2015. Read the notice at the SEC .
equity SEC